Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway

作者: Chie Shinoda , Muneharu Maruyama , Takashi Fujishita , Junichi Dohkan , Hirofumi Oda

DOI: 10.1002/IJC.21094

关键词: Multidrug Resistance-Associated Protein 1DoxorubicinKinaseBiologyImmunologyTransfectionCancer researchMultiple drug resistancec-junCell cultureLung cancerOncology

摘要: Multidrug resistance (MDR) is a major impediment to successful chemotherapy for lung cancer. Overexpression of multidrug resistance-associated protein 1 (MRP1) appears be involved in MDR development cancer cells. A number chemotherapeutic agents including doxorubicin (DOX) were reported induce MRP1 expression human In our study, we investigated the mechanism by which DOX induces small cell (SCLC) lines, GLC4 and NCI-H82. These cells expressed at low levels sensitive DOX. Doxorubicin 50 nM induced marked increase 24 hr, stimulated c-jun N-terminal kinase (JNK) activity. Treatment with JNK inhibitor, SP600125, significantly inhibited induction. Furthermore, transfection JNK1 JNK2 antisense oligonucleotides markedly DOX-induced expression. Chromatin immunoprecipitation assays revealed an enhanced recruitment phosphorylated promoter containing AP-1 site upon stimulation, was pretreatment SP600125. Surprisingly, exposed hr maintained increased least 3 weeks. Pretreatment SP600125 before stimulation blocked appearance phenotype as well induction findings suggest that activation may play essential role SCLC combined treatment inhibitor anticancer drugs prevent abrogation

参考文章(51)
Peter J. O'Dwyer, Andrew K. Godwin, Robert F. Ozols, Kang-Shen Yao, Thomas C. Hamilton, Steven W. Johnson, Evidence for Altered Regulation of γ-Glutamylcysteine Synthetase Gene Expression among Cisplatin-sensitive and Cisplatin-resistant Human Ovarian Cancer Cell Lines Cancer Research. ,vol. 55, pp. 4367- 4374 ,(1995)
Nanno Mulder, Jan Zijlstra, de Elisabeth G. E. Vries, Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Research. ,vol. 47, pp. 1780- 1784 ,(1987)
Michele L Taffaro, Bruce E Johnson, Ravi Salgia, Pasi A Jänne, Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Research. ,vol. 62, pp. 5242- 5247 ,(2002)
K Ueda, D P Clark, C J Chen, I B Roninson, M M Gottesman, I Pastan, The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. Journal of Biological Chemistry. ,vol. 262, pp. 505- 508 ,(1987) , 10.1016/S0021-9258(19)75806-2
Kurt C. Almquist, David R. Hipfner, Roger G. Deeley, Susan P. C. Cole, Caroline E. Grant, Gunnar Valdimarsson, Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research. ,vol. 54, pp. 357- 361 ,(1994)
Thomas M. Grogan, David R. Hipfner, Roger G. Deeley, Helen S. L. Chan, Susan P. C. Cole, Brenda L. Gallie, Ying Lu, Victor Ling, George Haddad, Multidrug Resistance Protein (MRP) Expression in Retinoblastoma Correlates with the Rare Failure of Chemotherapy despite Cyclosporine for Reversal of P-Glycoprotein Cancer Research. ,vol. 57, pp. 2325- 2330 ,(1997)
Chun-Xiao Wu, Wen-Pu Zhao, Hiroyuki Kishi, Junichi Dokan, Zhe-Xiong Jin, Xing-Cheng Wei, Kazunari K. Yokoyama, Atsushi Muraguchi, Activation of mouse RAG-2 promoter by Myc-associated zinc finger protein Biochemical and Biophysical Research Communications. ,vol. 317, pp. 1096- 1102 ,(2004) , 10.1016/J.BBRC.2004.03.159
Rong Yu, Alexander A. Shtil, Tse-Hua Tan, Igor B. Roninson, Ah-Ng Tony Kong, Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer Letters. ,vol. 107, pp. 73- 81 ,(1996) , 10.1016/0304-3835(96)04345-5
Takashi Fujishita, Massimo Loda, Ross E. Turner, Marinshine Gentler, Tatsuhiko Kashii, Oscar S. Breathnach, Bruce E. Johnson, Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel Oncology. ,vol. 64, pp. 399- 406 ,(2003) , 10.1159/000070299